EMBC
Embecta Corp.$3.29-0.10 (-2.81%)Prev Close$3.38·MCap$200.5M·P/E2.76·Vol1.39M·Yield0.14%
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
7
$2.44M
◆
Net Activity
Net Seller
$2.44M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Embecta Corp. (EMBC) has been exclusively selling, with 0 insider purchases totaling $0.00 and 7 insider sales totaling $2.44M. The most recent insider transaction was by Casner Jean (Chief Human Resources Officer), who sold $41.8K worth of shares on Nov 26, 2025. Embecta Corp. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $200.5M.
EMBC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | Casner Jean | Chief Human Resources Officer | Sell | 3,325 | $12.57 | $41.8K | 0 |
| Nov 26, 2025 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 15,380 | $12.57 | $193.3K | 0 |
| Nov 26, 2025 | Kurdikar Devdatt | President and CEO | Sell | 128,630 | $12.57 | $1.62M | 0 |
| Nov 26, 2025 | Elguicze Jacob | SVP and CFO | Sell | 24,782 | $12.57 | $311.5K | 273,228 |
| Nov 26, 2025 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 19,605 | $12.57 | $246.4K | 227,004 |
| Nov 26, 2025 | Roth Anthony M. | Chief Accounting Officer | Sell | 1,881 | $12.57 | $23.6K | 47,415 |
| Aug 9, 2025 | Casner Jean | Chief Human Resources Officer | Sell | 916 | $12.28 | $11.2K | 48,799 |
| May 23, 2025 | Melcher David F | Director | Buy | 10,000 | $10.60 | $106.0K | 0 |
| Apr 4, 2025 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 3,249 | $12.00 | $39.0K | 0 |
| Apr 4, 2025 | Kurdikar Devdatt | President and CEO | Sell | 39,592 | $12.00 | $475.1K | 0 |
| Apr 4, 2025 | Elguicze Jacob | SVP and CFO | Sell | 4,948 | $12.00 | $59.4K | 168,599 |
| Apr 4, 2025 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 5,285 | $12.00 | $63.4K | 139,439 |
| Feb 25, 2025 | Melcher David F | Director | Buy | 13,000 | $13.67 | $177.6K | 0 |
| Feb 12, 2025 | Morris Milton Mayo | Director | Sell | 3,100 | $16.38 | $50.8K | 36,133 |
| Nov 26, 2024 | Casner Jean | Chief Human Resources Officer | Sell | 1,281 | $18.70 | $24.0K | 48,288 |
| Nov 26, 2024 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 5,806 | $18.70 | $108.6K | 61,388 |
| Nov 26, 2024 | Elguicze Jacob | SVP and CFO | Sell | 9,785 | $18.70 | $183.0K | 170,882 |
| Nov 26, 2024 | Kurdikar Devdatt | President and CEO | Sell | 48,956 | $18.70 | $915.5K | 531,240 |
| Nov 26, 2024 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 8,016 | $18.70 | $149.9K | 142,568 |
| Aug 9, 2024 | Casner Jean | Chief Human Resources Officer | Sell | 916 | $15.39 | $14.1K | 26,000 |
| May 10, 2024 | Elguicze Jacob | SVP and CFO | Sell | 1,013 | $14.24 | $14.4K | 117,633 |
| Apr 4, 2024 | Kurdikar Devdatt | President and CEO | Sell | 4,535 | $12.78 | $58.0K | 388,005 |
| Feb 12, 2024 | Melcher David F | Director | Buy | 2,000 | $16.25 | $32.5K | 45,080 |
| Feb 11, 2024 | Kurdikar Devdatt | President and CEO | Sell | 17,165 | $16.26 | $279.1K | 389,940 |
| Nov 26, 2023 | Capone Brian | VP, CAO & Corp. Controller | Sell | 892 | $17.49 | $15.6K | 21,054 |
| Nov 26, 2023 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 4,351 | $17.49 | $76.1K | 40,335 |
| Nov 26, 2023 | Elguicze Jacob | SVP and CFO | Sell | 5,486 | $17.49 | $96.0K | 117,717 |
| Nov 26, 2023 | Kurdikar Devdatt | President and CEO | Sell | 18,431 | $17.49 | $322.4K | 405,034 |
| Nov 26, 2023 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 3,715 | $17.49 | $65.0K | 97,359 |
| Sep 8, 2023 | Melcher David F | Director | Buy | 6,233 | $15.77 | $98.3K | 27,698+29% |
| Aug 10, 2023 | Elguicze Jacob | SVP and CFO | Buy | 4,625 | $21.66 | $100.2K | 66,027 |
| Aug 10, 2023 | Kurdikar Devdatt | President and CEO | Buy | 5,000 | $21.81 | $109.0K | 244,791 |
| Aug 10, 2023 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Buy | 4,700 | $21.67 | $101.8K | 55,333 |
| May 10, 2023 | Elguicze Jacob | SVP and CFO | Sell | 988 | $29.58 | $29.2K | 61,402 |
| Apr 4, 2023 | Kurdikar Devdatt | President and CEO | Sell | 4,875 | $27.36 | $133.4K | 239,451 |
| Feb 15, 2023 | Melcher David F | Director | Buy | 3,100 | $32.51 | $100.8K | 21,465 |
| Feb 11, 2023 | Kurdikar Devdatt | President and CEO | Sell | 2,109 | $28.51 | $60.1K | 244,326 |
| Jan 27, 2023 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 920 | $27.40 | $25.2K | 26,103 |
| Nov 26, 2022 | Capone Brian | VP, CAO & Corp. Controller | Sell | 417 | $33.04 | $13.8K | 8,223 |
| Nov 26, 2022 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 2,191 | $33.04 | $72.4K | 27,023 |
| Nov 26, 2022 | Elguicze Jacob | SVP and CFO | Sell | 1,334 | $33.04 | $44.1K | 62,390 |
| Nov 26, 2022 | Kumar Ajay | SVP and CHRO | Sell | 1,806 | $33.04 | $59.7K | 28,444 |
| Nov 26, 2022 | Kurdikar Devdatt | President and CEO | Sell | 4,428 | $33.04 | $146.3K | 246,435 |
| Nov 26, 2022 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 1,431 | $33.04 | $47.3K | 50,633 |
EMBC Insider Buying Activity
The following table shows recent insider purchases of Embecta Corp. (EMBC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 23, 2025 | Melcher David F | Director | Buy | 10,000 | $10.60 | $106.0K | 0 |
| Feb 25, 2025 | Melcher David F | Director | Buy | 13,000 | $13.67 | $177.6K | 0 |
| Feb 12, 2024 | Melcher David F | Director | Buy | 2,000 | $16.25 | $32.5K | 45,080 |
| Sep 8, 2023 | Melcher David F | Director | Buy | 6,233 | $15.77 | $98.3K | 27,698+29% |
| Aug 10, 2023 | Elguicze Jacob | SVP and CFO | Buy | 4,625 | $21.66 | $100.2K | 66,027 |
| Aug 10, 2023 | Kurdikar Devdatt | President and CEO | Buy | 5,000 | $21.81 | $109.0K | 244,791 |
| Aug 10, 2023 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Buy | 4,700 | $21.67 | $101.8K | 55,333 |
| Feb 15, 2023 | Melcher David F | Director | Buy | 3,100 | $32.51 | $100.8K | 21,465 |
EMBC Insider Selling Activity
The following table shows recent insider sales of Embecta Corp. (EMBC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | Casner Jean | Chief Human Resources Officer | Sell | 3,325 | $12.57 | $41.8K | 0 |
| Nov 26, 2025 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 15,380 | $12.57 | $193.3K | 0 |
| Nov 26, 2025 | Kurdikar Devdatt | President and CEO | Sell | 128,630 | $12.57 | $1.62M | 0 |
| Nov 26, 2025 | Elguicze Jacob | SVP and CFO | Sell | 24,782 | $12.57 | $311.5K | 273,228 |
| Nov 26, 2025 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 19,605 | $12.57 | $246.4K | 227,004 |
| Nov 26, 2025 | Roth Anthony M. | Chief Accounting Officer | Sell | 1,881 | $12.57 | $23.6K | 47,415 |
| Aug 9, 2025 | Casner Jean | Chief Human Resources Officer | Sell | 916 | $12.28 | $11.2K | 48,799 |
| Apr 4, 2025 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 3,249 | $12.00 | $39.0K | 0 |
| Apr 4, 2025 | Kurdikar Devdatt | President and CEO | Sell | 39,592 | $12.00 | $475.1K | 0 |
| Apr 4, 2025 | Elguicze Jacob | SVP and CFO | Sell | 4,948 | $12.00 | $59.4K | 168,599 |
| Apr 4, 2025 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 5,285 | $12.00 | $63.4K | 139,439 |
| Feb 12, 2025 | Morris Milton Mayo | Director | Sell | 3,100 | $16.38 | $50.8K | 36,133 |
| Nov 26, 2024 | Casner Jean | Chief Human Resources Officer | Sell | 1,281 | $18.70 | $24.0K | 48,288 |
| Nov 26, 2024 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 5,806 | $18.70 | $108.6K | 61,388 |
| Nov 26, 2024 | Elguicze Jacob | SVP and CFO | Sell | 9,785 | $18.70 | $183.0K | 170,882 |
| Nov 26, 2024 | Kurdikar Devdatt | President and CEO | Sell | 48,956 | $18.70 | $915.5K | 531,240 |
| Nov 26, 2024 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 8,016 | $18.70 | $149.9K | 142,568 |
| Aug 9, 2024 | Casner Jean | Chief Human Resources Officer | Sell | 916 | $15.39 | $14.1K | 26,000 |
| May 10, 2024 | Elguicze Jacob | SVP and CFO | Sell | 1,013 | $14.24 | $14.4K | 117,633 |
| Apr 4, 2024 | Kurdikar Devdatt | President and CEO | Sell | 4,535 | $12.78 | $58.0K | 388,005 |
| Feb 11, 2024 | Kurdikar Devdatt | President and CEO | Sell | 17,165 | $16.26 | $279.1K | 389,940 |
| Nov 26, 2023 | Capone Brian | VP, CAO & Corp. Controller | Sell | 892 | $17.49 | $15.6K | 21,054 |
| Nov 26, 2023 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 4,351 | $17.49 | $76.1K | 40,335 |
| Nov 26, 2023 | Elguicze Jacob | SVP and CFO | Sell | 5,486 | $17.49 | $96.0K | 117,717 |
| Nov 26, 2023 | Kurdikar Devdatt | President and CEO | Sell | 18,431 | $17.49 | $322.4K | 405,034 |
| Nov 26, 2023 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 3,715 | $17.49 | $65.0K | 97,359 |
| May 10, 2023 | Elguicze Jacob | SVP and CFO | Sell | 988 | $29.58 | $29.2K | 61,402 |
| Apr 4, 2023 | Kurdikar Devdatt | President and CEO | Sell | 4,875 | $27.36 | $133.4K | 239,451 |
| Feb 11, 2023 | Kurdikar Devdatt | President and CEO | Sell | 2,109 | $28.51 | $60.1K | 244,326 |
| Jan 27, 2023 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 920 | $27.40 | $25.2K | 26,103 |
| Nov 26, 2022 | Capone Brian | VP, CAO & Corp. Controller | Sell | 417 | $33.04 | $13.8K | 8,223 |
| Nov 26, 2022 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Sell | 2,191 | $33.04 | $72.4K | 27,023 |
| Nov 26, 2022 | Elguicze Jacob | SVP and CFO | Sell | 1,334 | $33.04 | $44.1K | 62,390 |
| Nov 26, 2022 | Kumar Ajay | SVP and CHRO | Sell | 1,806 | $33.04 | $59.7K | 28,444 |
| Nov 26, 2022 | Kurdikar Devdatt | President and CEO | Sell | 4,428 | $33.04 | $146.3K | 246,435 |
| Nov 26, 2022 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Sell | 1,431 | $33.04 | $47.3K | 50,633 |
EMBC Insiders
Similar Stocks to EMBC
VTRS
Viatris Inc.
$15.82-2.74%
$18.94B
ELAN
Elanco Animal Health Incorporated
$23.70-0.61%
$11.92B
INDV
Indivior Pharmaceuticals Inc
$34.95-3.11%
$4.72B
AMRX
Amneal Pharmaceuticals, Inc.
$12.84-2.54%
$4.08B
SUPN
Supernus Pharmaceuticals, Inc.
$44.94-2.77%
$2.77B
ANIP
ANI Pharmaceuticals, Inc.
$76.54-2.43%
$1.88B
PAHC
Phibro Animal Health Corporation
$29.71-3.39%
$1.35B
HROW
Harrow Health, Inc.
$34.34-2.48%
$1.28B